TERT and glioblastoma: Among 1008 IDH-wildtype glioblastomas WHO grade 4, TERT promotor status was available in 466 patients including 396 individuals with (IDHwt/TERTmut) and 70 patients without TERT promotor mutations (IDHwt/TERTwt).